| Effect | Decrease |
| Trial Design | Non-randomized controlled trial |
| Trial Length | 1-6 months |
| Number of Subjects | 60 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64 |
| Body Types | Overweight |
Supplementation of 2.5mL of nigella sativa oil for six weeks to medicated diabetics (unblinded study) was able to enhance the hypoglycemic and cholesterol reducing properties of the standard antidiabetic therapy although it was without influence on triglycerides or HDL-C.
